Ireland
--:--IST
Latest
Clinical Trials in France / NCT07207005
Recruiting Not applicable

Comparison of Wear Between Two Dual-mobility Acetabular Cups in Patients Undergoing Total Hip Arthroplasty

NCT07207005 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-07-30
Last updated
2026-08-20

Condition(s) studied

Hip Arthroplasty Replacement

Investigational drug(s) / intervention(s)

ECIMA CORINCORIN

ECIMA CORIN: Mobile cup (Corin) made of highly cross-linked PE doped with vitamin E (ECIMA, Corin).

CORIN: Mobile cupule (Corin) is made of conventional PE

Study summary

In 2022, data from the UK's National Joint Registry (NJR) and the American Joint Replacement Registry (AJRR) indicated that Total Hip Replacement (THR) is the most commonly performed orthopaedic joint surgery.

The NJR has observed that between 10 and 20% of hip implants require revision within the first 10 years. The main reasons for these revisions include implant fractures, joint incompatibility, aseptic loosening, dislocation and wear of the polyethylene (PE) insert.

To address this problem, highly cross-linked polyethylene (HXLPE) inserts have been developed. Cross-linking helps to limit wear on polyethylene prostheses in total hip arthroplasty. However, there are concerns about the loss of elasticity of HXLPE and oxidation after implantation.

A new generation of inserts based on highly cross-linked polyethylene (irradiation dose ≥100 Kgy), enriched with vitamin E, has been developed. This PE, called ECIMA, was developed to maintain mechanical properties, minimise PE wear and improve long-term oxidation resistance.

In the HAS evaluation report on highly cross-linked polyethylene inserts dated 24 January 2023, data from the literature show less wear of highly cross-linked polyethylene compared to conventional polyethylene.

Nevertheless, the use of highly cross-linked polyethylene is not yet the gold standard. Furthermore, the data in the literature mainly concern single-mobility cups but not double-mobility cups. Finally, new imaging protocols now make it possible to assess the wear of prosthesis materials more accurately.

In this context, it seems appropriate to conduct a French study comparing double-mobility cups containing highly cross-linked polyethylene or conventional polyethylene inserts.

Eligibility

Sex
ALL
Min age
55 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Patient, male or female, aged between 55 and 80. * Patient with a life expectancy \> 5 years at the time of inclusion. * Patient scheduled to undergo primary total hip arthroplasty with a dual-mobility cup prosthesis. * Patient affiliated with or beneficiary of a social security scheme. * Patient who speaks French and has signed an informed consent form. Exclusion Criteria: * Patients with a contraindication mentioned in the instructions for use of the medical device under investigation * Patients with an ASA score of 4 * Protected patients: adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision * Patients participating in another clinical study whose objectives could interfere with this study

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpital Privé Jean Mermoz Lyon France Recruiting

More GCS Ramsay Santé pour l'Enseignement et la Recherche trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07207005 on ClinicalTrials.gov ↗ ← All trials in France